Search results
Another Approach To Checkpoint Inhibitors: Targeting Receptors
Forbes· 5 days agoAn alternative to PD-1 targeting cancer therapies, PD-L1 checkpoint inhibitors boost antitumor...
Nano-immunotherapy developed to improve lung cancer treatment
Medical Xpress· 8 hours agoThe team showed promising results for the new therapy in cancer cells in the lab and in mouse lung tumor models, with potential applications for improving care and outcomes for patients with ...
Immunotherapy Before Surgery Leads to Better Outcomes for People with Colon Cancer
Healthline via AOL· 6 days agoDoctors administered the patients two different immunotherapy drugs prior to surgery. The drugs,...
Obesity-cancer connection discovery suggests strategies for improving immunotherapy
Medical Xpress· 2 days agoObesity increases the frequency of macrophages in tumors and induces their expression of the immune checkpoint protein PD-1—a target of cancer immunotherapies. The findings ...
S3 Episode 5: Important Advances in Small Cell Lung Cancer
Medscape· 4 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
To Your Good Health: The cause behind a case of CMML seems to be unknown
The Marshall News Messenger· 12 hours agoAccording to his death certificate, he died of lung cancer (not a surprise) and chronic...
West Cancer Center & Research Institute specialists featured at prestigious oncology event - Memphis...
The Business Journals· 2 days agoSix of West Cancer Center & Research Institute’s oncology specialists presented key research on very...
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
FOX40 Sacramento· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 3 days agoAlong with...Peak said the funds will also go towards accelerating its wider pipeline of...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
The Joplin Globe· 5 days agoTORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...